Latest News

Vials and Syringe on White Table with Background Windows Stock Photo | ©
Secukinumab Found Cost-Effective for Patients With Moderate to Severe Psoriasis

September 28th 2023

Compared with other biologics frequently used in China for moderate-to-severe psoriasis, secukinumab is the most cost-effective treatment option.

brain colorful | Image credit: vegefox -
EC Approves First MS Biosimilar; Coherus Receives CRL for Neulasta Onpro Competitor

September 27th 2023

Japan flag in Tokyo | Image credit: Savvapanf Photo © -
Alvotech’s Stelara Biosimilar Approved in Japan

September 25th 2023

Doctor with human Eye anatomy model | Image Credit: ©  Jo Panuwat D-
Higher-Cost Therapies for ARMD Could Contribute to Heightened Medicare Costs; Biosimilars Could Help

September 24th 2023

old woman eye | Image credit: Syda Productions -
European Commission Approves First Aflibercept Biosimilar

September 21st 2023

Video Interviews
CfB podcast banner
CFB podcast banner
CfB podcast banner
cfb podcast banner
CfB podcast banner
cfb podcast banner
image of adalimumab biosmilar eveloped by alvotech prefilled syring
CfB podcast banner
CfB podcast banner
CfB podcast banner

More News

© 2023 MJH Life Sciences

All rights reserved.